Effect of Statin Therapy on Glycated Hemoglobin Levels in Nondiabetic Individuals Attending Cardiology Outpatient Department

Background: Statins are widely recognized for their efficacy in reducing lipid levels and cardiovascular disease risk.However, prolonged statin therapy has been associated with type 2 diabetes mellitus (T2DM).This study evaluates the relationship between statin use and glycemic changes, focusing on fasting blood sugar (FBS), glycated hemoglobin (HbA1c), total bilirubin, therapy duration, and gender.Materials and methods: A sample of 100 individuals on statin therapy was analyzed after obtaining institutional ethical committee approval and patient consent.Participants were grouped based on HbA1c levels as nondiabetic (<5.7%), prediabetic (5.7-6.4%), and diabetic (>6.4%).The duration of therapy was categorized into 3 to <6 months, 6-12 months, and >12 months.Statistical analysis, including the Chi-square test, assessed the association between statin use and glycemic status.Results: Among the participants, 61% were diabetic, 23% prediabetic, and 16% nondiabetic.As a primary analysis, prolonged statin use (>12 months) correlated with elevated FBS and HbA1c levels, indicating a dose-dependent relationship.Secondary analysis of this study included the following findings: Statin use reduced total bilirubin levels, potentially increasing oxidative stress and had a strong significance, with a p-value of 0.000136.Duration of statin therapy had no significance or a significance on the edge with a p-value of 0.056846.Gender analysis revealed no significant differences in glycemic outcomes with a p-value > 0.05, suggesting that statins affect glucose metabolism similarly in males and females.Conclusions: Prolonged statin therapy is associated with impaired glycemic control, particularly in individuals at high risk for metabolic disorders.Regular monitoring of glycemic parameters in statin users is recommended to balance cardiovascular benefits with potential T2DM risks.Further research is needed to explore mechanisms and strategies to mitigate these effects.

Authors

Publication Details

Journal
Indian Journal of Medical Biochemistry
Published
2025-08-30
DOI
https://doi.org/10.5005/jp-journals-10054-0281
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Statin Therapy on Glycated Hemoglobin Levels in Nondiabetic Individuals Attending Cardiology Outpatient Department

Swathi Vajja, Balu Mahendran Kanumuru, Kirmani Natukula, Spoorthi Nutakki et al.
Indian Journal of Medical Biochemistry
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Effect of Statin Therapy on Glycated Hemoglobin Levels in Nondiabetic Individuals Attending Cardiology Outpatient Department

Swathi Vajja, Balu Mahendran Kanumuru, Kirmani Natukula, Spoorthi Nutakki, R. Pathan, Ruthamma Pallepogu, Khaja N Shaik, Sushma Annam
article en

Abstract

Background: Statins are widely recognized for their efficacy in reducing lipid levels and cardiovascular disease risk.However, prolonged statin therapy has been associated with type 2 diabetes mellitus (T2DM).This study evaluates the relationship between statin use and glycemic changes, focusing on fasting blood sugar (FBS), glycated hemoglobin (HbA1c), total bilirubin, therapy duration, and gender.Materials and methods: A sample of 100 individuals on statin therapy was analyzed after obtaining institutional ethical committee approval and patient consent.Participants were grouped based on HbA1c levels as nondiabetic (<5.7%), prediabetic (5.7-6.4%), and diabetic (>6.4%).The duration of therapy was categorized into 3 to <6 months, 6-12 months, and >12 months.Statistical analysis, including the Chi-square test, assessed the association between statin use and glycemic status.Results: Among the participants, 61% were diabetic, 23% prediabetic, and 16% nondiabetic.As a primary analysis, prolonged statin use (>12 months) correlated with elevated FBS and HbA1c levels, indicating a dose-dependent relationship.Secondary analysis of this study included the following findings: Statin use reduced total bilirubin levels, potentially increasing oxidative stress and had a strong significance, with a p-value of 0.000136.Duration of statin therapy had no significance or a significance on the edge with a p-value of 0.056846.Gender analysis revealed no significant differences in glycemic outcomes with a p-value > 0.05, suggesting that statins affect glucose metabolism similarly in males and females.Conclusions: Prolonged statin therapy is associated with impaired glycemic control, particularly in individuals at high risk for metabolic disorders.Regular monitoring of glycemic parameters in statin users is recommended to balance cardiovascular benefits with potential T2DM risks.Further research is needed to explore mechanisms and strategies to mitigate these effects.

Indian Journal of Medical BiochemistryVol. 29(3)
Openalex Percentile: Top 68%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effect of Statin Therapy on Glycated Hemoglobin Levels in Nondiabetic Individuals Attending Cardiology Outpatient Department — Swathi Vajja, Balu Mahendran Kanumuru, et al. · Indian Journal of Medical Biochemistry (2025) | TGRS Research Map | TGRS